Breast Density, Body Mass Index, and Risk of Tumor Marker-Defined Subtypes of Breast Cancer

Annals of Epidemiology

Volumn 22, Issue 5, 2012, Pages 340-348

  Phipps, Amanda I ^a,b   Buist, Diana S M ^b,c   Malone, Kathleen E ^a,b   Barlow, William E ^a,b,c   Porter, Peggy L ^a,d   Kerlikowske, Karla ^e   O'Meara, Ellen S ^c   Li, Christopher I ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body Mass Index; Breast Cancer; Breast Density; Estrogen Receptor; HER2; Progesterone Receptor; Triple Negative

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BODY DENSITY; BODY MASS; BREAST CANCER; BREAST DENSITY; CANCER CLASSIFICATION; CANCER RISK; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; TRIPLE NEGATIVE BREAST CANCER;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; POPULATION SURVEILLANCE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK; UNITED STATES;

EID: 84862799485     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.02.002     Document Type: Article

References (53)

1. McCormack V.A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-1169.
2. Greendale G.A., Reboussin B.A., Slone S., Wasilauskas C., Pike M.C., Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003, 95:30-37.
3. McTiernan A., Martin C.F., Peck J.D., Aragaki A.K., Chlebowski R.T., Pisano E.D., et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's health initiative randomized trial. J Natl Cancer Inst 2005, 97:1366-1376.
4. Vachon C.M., Kuni C.C., Anderson K., Anderson V.E., Sellers T.A. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 2000, 11:653-662.
5. Butler L.M., Gold E.B., Greendale G.A., Crandall C.J., Modugno F., Oestreicher N., et al. Menstrual and reproductive factors in relation to mammographic density: The Study of Women's Health Across the Nation (SWAN). Breast Cancer Res Treat 2008, 112:165-174.
6. El-Bastawissi A.Y., White E., Mandelson M.T., Taplin S.H. Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control 2000, 11:955-963.
7. Bremnes Y., Ursin G., Bjurstam N., Rinaldi S., Kaaks R., Gram I.T. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Int J Cancer 2007, 121:2506-2511.
8. Johansson H., Gandini S., Bonanni B., Mariette F., Guerrieri-Gonzaga A., Serrano D., et al. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat 2008, 108:57-67.
9. Warren R., Skinner J., Sala E., Denton E., Dowsett M., Folkerd E., et al. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15:1502-1508.
10. McCormack V.A., dos Santos Silva I., De Stavola B.L., Perry N., Vinnicombe S., Swerdlow A.J., et al. Life-course body size and perimenopausal mammographic parenchymal patterns in the MRC 1946 British birth cohort. Br J Cancer 2003, 89:852-859.
11. Key T.J., Appleby P.N., Reeves G.K., Roddam A., Dorgan J.F., Longcope C., et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003, 95:1218-1226.
12. Enger S.M., Ross R.K., Paganini-Hill A., Carpenter C.L., Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: Results from two case-control studies. Cancer Epidemiol Biomarkers Prev 2000, 9:681-687.
13. Althuis M.D., Fergenbaum J.H., Garcia-Closas M., Brinton L.A., Madigan M.P., Sherman M.E. Etiology of hormone receptor-defined breast cancer: A systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004, 13:1558-1568.
14. Li C.I., Malone K.E., Daling J.R. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States). Cancer Causes Control 2006, 17:695-703.
15. Suzuki R., Orsini N., Saji S., Key T.J., Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int J Cancer 2009, 124:698-712.
16. Kerlikowske K., Walker R., Miglioretti D.L., Desai A., Ballard-Barbash R., Buist D.S. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst 2008, 100:1724-2733.
17. Ziv E., Tice J., Smith-Bindman R., Shepherd J., Cummings S., Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004, 13:2090-2095.
18. Ma H., Luo J., Press M.F., Wang Y., Bernstein L., Ursin G. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 2009, 18:479-485.
19. Aiello E.J., Buist D.S., White E., Porter P.L. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 2005, 14:662-668.
20. Ghosh K., Brandt K.R., Sellers T.A., Reynolds C., Scott C.G., Maloney S.D., et al. Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008, 17:872-879.
21. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
22. Sorlie T. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 2004, 40:2667-2675.
23. Lacroix M., Toillon R.A., Leclercq G. Stable 'portrait' of breast tumors during progression: Data from biology, pathology and genetics. Endocr Relat Cancer 2004, 11:497-522.
24. Ballard-Barbash R., Taplin S.H., Yankaskas B.C., Ernster V.L., Rosenberg R.D., Carney P.A., et al. Breast Cancer Surveillance Consortium: A national mammography screening and outcomes database. AJR Am J Roentgenol 1997, 169:1001-1008.
25. Breast Cancer Surveillence Consortium. Data Elements, Questionnaires & Standard Definitions. Available at: Accessed February 10, 2012. http://breastscreening.cancer.gov/data/elements.html.
26. American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) 2003, American College of Radiology, American College of Radiology, Reston, VA. 4th ed.
27. Tice J.A., Cummings S.R., Smith-Bindman R., Ichikawa L., Barlow W.E., Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model. Ann Intern Med 2008, 148:337-347.
28. van den Brandt P.A., Spiegelman D., Yaun S.S., Adami H.O., Beeson L., Folsom A.R., et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000, 152:514-527.
29. Raghunathan T.E., Lepkowski J.M., Van Hoewyk J., Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Method 2001, 27:85-95.
30. Kelemen L.E., Pankratz V.S., Sellers T.A., Brandt K.R., Wang A., Janney C., et al. Age-specific trends in mammographic density: The Minnesota Breast Cancer Family Study. Am J Epidemiol 2008, 167:1027-1036.
31. del Carmen M.G., Hughes K.S., Halpern E., Rafferty E., Kopans D., Parisky Y.R., et al. Racial differences in mammographic breast density. Cancer 2003, 98:590-596.
32. van der Heijden G.J.M.G., Donders A.R.T., Stijnen T., Moons K.G.M. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: A clinical example. J Clin Epidemiol 2006, 59:1102-1109.
33. Sterne J.A., White I.R., Carlin J.B., Spratt M., Royston P., Kenward M.G., et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ 2009, 338:b2393.
34. Elgar F.J., Stewart J.M. Validity of self-report screening for overweight and obesity. Evidence from the Canadian Community Health Survey. Can J Public Health 2008, 99:423-427.
35. Nicholson B.T., LoRusso A.P., Smolkin M., Bovbjerg V.E., Petroni G.R., Harvey J.A. Accuracy of assigned BI-RADS breast density category definitions. Acad Radiol 2006, 13:1143-1149.
36. Phipps A.I., Malone K.E., Porter P.L., Daling J.R., Li C.I. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008, 17:2078-2086.
37. Phipps A.I., Chlebowski R.T., Prentice R., McTiernan A., Stefanick M.L., Wactawski-Wende J., et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011, 20:454-463.
38. Yang X.R., Sherman M.E., Rimm D.L., Lissowska J., Brinton L.A., Peplonska B., et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007, 16:439-443.
39. Millikan R.C., Newman B., Tse C.K., Moorman P.G., Conway K., Smith L.V., et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008, 109:123-139.
40. Dolle J.M., Daling J.R., White E., Brinton L.A., Doody D.R., Porter P.L., et al. Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 2009, 18:1157-1166.
41. Trivers K.F., Lund M.J., Porter P.L., Liff J.M., Flagg E.W., Coates R.J., et al. The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 2009, 20:1071-1082.
42. Magoffin D.A., Weitsman S.R., Aagarwal S.K., Jakimiuk A.J. Leptin regulation of aromatase activity in adipose stromal cells from regularly cycling women. Ginekol Pol 1999, 70:1-7.
43. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
44. Greendale G.A., Palla S.L., Ursin G., Laughlin G.A., Crandall C., Pike M.C., et al. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: Results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol 2005, 162:826-834.
45. Boyd N.F., Martin L.J., Yaffe M.J., Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011, 13:223.
46. Ding J., Warren R., Girling A., Thompson D., Easton D. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 2010, 16:279-289.
47. Conroy S.M., Pagano I., Kolonel L.N., Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: The Multiethnic Cohort Study. Cancer Epidemiol 2011, 35:448-452.
48. Yaghjyan L., Colditz G.A., Collins L.C., Schnitt S.J., Rosner B., Vachon C., et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 2011, 103:1179-1189.
49. Yang W.T., Dryden M., Broglio K., Gilcrease M., Dawood S., Dempsey P.J., et al. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 2008, 111:405-410.
50. Diorio C., Pollak M., Byrne C., Masse B., Hebert-Croteau N., Yaffe M., et al. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005, 14:1065-1073.
51. Boyd N.F., Stone J., Martin L.J., Jong R., Fishell E., Yaffe M., et al. The association of breast mitogens with mammographic densities. Br J Cancer 2002, 87:876-882.
52. Byrne C., Colditz G.A., Willett W.C., Speizer F.E., Pollak M., Hankinson S.E. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res. 2000, 60:3744-3748.
53. Greendale G.A., Huang M.H., Ursin G., Ingles S., Stanczyk F., Crandall C., et al. Serum prolactin levels are positively associated with mammographic density in postmenopausal women. Breast Cancer Res Treat 2007, 105:337-346.